Pharmaceutical News

RSS

Bristol-Myers Squibb to review key accomplishments at meeting with investment community

During a meeting with the investment community today, Bristol-Myers Squibb Company will provide a comprehensive business overview, highlight positive pipeline developments and provide 2013 minimum non-GAAP earnings per share guidance.

5 Mar 2010

Research reveals maple syrup and maple water contain abscisic acid

Thanks to modern science, the closely guarded secrets of one of our nation's most distinctive emblems, maple syrup, are now being revealed. It has recently been reported that maple syrup contains polyphenols and shows ORAC values which compare to commonly eaten fruits and vegetables such as broccoli.

5 Mar 2010

CVS calls for Senate and House Health Committees to hold public hearings on vaccine safety

The Coalition for Vaccine Safety (CVS) comprises organizations representing over 75,000 families dedicated to vaccine safety. It formed in February 2010 to address urgent concerns about insufficient vaccine safety science. On February 24, it called on Senate and House Health Committees to hold public hearings on vaccine safety.

5 Mar 2010

Vioxx: Australian Court dismisses all claims against Merck

Today, the Federal Court in Australia published its judgment in the Peterson case. The Court found against MSD Australia on two claims under Australian statutory provisions. The Court dismissed all claims against Merck & Co., Inc. specifically finding that Merck was not negligent in its development, scientific study and sale of Vioxx. Merck and MSD Australia disagree with the limited portions of the Court’s findings that were against MSD Australia and intend to appeal them.

5 Mar 2010

Forteo to remain Decision Resources' proprietary clinical gold standard for treatment of osteoporosis

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a drug's effect on reduction of new hip fractures is the attribute that most influences U.S. and European surveyed primary care physicians' (PCPs') prescribing decisions in osteoporosis.

5 Mar 2010

Study finds Pfizer's pneumonia, meningitis vaccine protects against recurrent pneumonia in HIV patients

Pfizer's Prevnar 7 vaccine, which protects against pneumonia and meningitis, has been shown to reduce the risk of recurrent pneumococcal infection in patients living with HIV in Malawi, according to a study published Thursday in the New England Journal of Medicine, Reuters reports.

5 Mar 2010

KAPIDEX to be marketed as DEXILANT in the U.S.

Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX™ (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANT™ (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.

5 Mar 2010

FDA's 5-year NCE exclusivity grant to VYVANSE: Court upholds decision

Shire plc, the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year New Chemical Entity ("NCE") exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).

5 Mar 2010

GSK's Japanese subsidiary begins voluntary recall of Poligrip products containing zinc

Today, the Japanese subsidiary of pharmaceutical giant, GlaxoSmithKline (GSK), announced that it would begin a voluntary recall of Poligrip products that contain zinc in that country Friday. The company's decision followed just three reports of adverse health effects in consumers of the product, sold in Japan as Poligrip EX.

5 Mar 2010

FDA approves CSL Behring's Hizentra for PI

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for HizentraTM, Immune Globulin Subcutaneous (Human), 20% Liquid, for treating patients diagnosed with primary immunodeficiency (PI). A once weekly immunoglobulin (Ig) replacement therapy, Hizentra provides effective protection against infection by maintaining a steady and normal level of immunoglobulin in the body.

4 Mar 2010

Heartburn drug Kapidex to be marketed under new name Dexilant

The U.S. Food and Drug Administration has approved a name change for the heartburn drug Kapidex (dexlansoprazole) to avoid confusion with two other medications – Casodex and Kadian. Effective in late April 2010, Takeda Pharmaceuticals North America Inc. will market Kapidex under the new name Dexilant.

4 Mar 2010

Vaxart raises $12.5M to advance Phase I clinical trials on Avian flu vaccine

Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has closed a $12.5 million Series B financing, led by Care Capital of Princeton NJ. The funding will be used to advance the Company's lead product, an oral vaccine for Avian influenza, through Phase I clinical trials.

4 Mar 2010

Washington State cracks down on prescription fraud with new paper and ink

The Seattle Post Intelligencer/Everett Herald: "Patients who get written prescriptions will see changes this summer aimed at curbing fraud. Come July 1, prescriptions will be printed on tamper-resistant paper with Mission Impossible-like ink that changes color when rubbed with a finger.

4 Mar 2010

Watson Pharmaceuticals to acquire U.S. rights to Columbia's bioadhesive progesterone gel products

Watson Pharmaceuticals, Inc. today announced an agreement to expand their Women's Health brand product portfolio with the acquisition of the exclusive U.S. rights to Columbia Laboratories, Inc.'s bioadhesive progesterone gel products currently marketed under the trade names CRINONE® and PROCHIEVE® for the indications of infertility and secondary amenorrhea.

4 Mar 2010

Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs

Diplomat Specialty Pharmacy, the nation's largest privately held specialty pharmacy company, is on a mission to help patients obtain the financial assistance they need to purchase life-saving drugs for such illnesses as cancer, HIV/AIDS and Hepatitis C, as well as drugs for Multiple Sclerosis, kidney disease and other chronic conditions.

4 Mar 2010

SpePharm Holding acquires global rights to Savene from TopoTarget

SpePharm Holding, BV today announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S (Copenhagen, Denmark). As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget since its approval by the EMEA in July 2006, is the only approved product for the treatment of extravasations, or leakage out of the blood stream, of certain commonly used anticancer drugs known as anthracyclines.

4 Mar 2010

Atacama Labs and Excella partner to sell PDG Granule and Tablet Manufacturing Services

Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.

4 Mar 2010

Mosaic vaccines show promise in reducing HIV spread

Two teams of researchers-including Los Alamos National Laboratory theoretical biologists Bette Korber, Will Fischer, Sydeaka Watson, and James Szinger-have announced an HIV vaccination strategy that has been shown to expand the breadth and depth of immune responses in rhesus monkeys. Rhesus monkeys provide the best animal model currently available for testing HIV vaccines.

4 Mar 2010

Longer wait for radiation treatment after breast cancer surgery increases risk of recurrence in older women

The longer older women wait for radiation treatment after undergoing surgery for breast cancer, the greater the chances of the disease coming back, an international team of scientists has warned.

4 Mar 2010

Childhood absence epilepsy: Comparative clinical trial of widely used anti-seizure drugs

The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy - the most common form of epilepsy in kids - has established an evidence-based approach for initial drug therapy.

4 Mar 2010

Pharmaceutical News

Bristol-Myers Squibb to review key accomplishments at meeting with investment community

Research reveals maple syrup and maple water contain abscisic acid

CVS calls for Senate and House Health Committees to hold public hearings on vaccine safety

Vioxx: Australian Court dismisses all claims against Merck

Forteo to remain Decision Resources' proprietary clinical gold standard for treatment of osteoporosis

Study finds Pfizer's pneumonia, meningitis vaccine protects against recurrent pneumonia in HIV patients

KAPIDEX to be marketed as DEXILANT in the U.S.

FDA's 5-year NCE exclusivity grant to VYVANSE: Court upholds decision

GSK's Japanese subsidiary begins voluntary recall of Poligrip products containing zinc

FDA approves CSL Behring's Hizentra for PI

Heartburn drug Kapidex to be marketed under new name Dexilant

Vaxart raises $12.5M to advance Phase I clinical trials on Avian flu vaccine

Washington State cracks down on prescription fraud with new paper and ink

Watson Pharmaceuticals to acquire U.S. rights to Columbia's bioadhesive progesterone gel products

Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs

SpePharm Holding acquires global rights to Savene from TopoTarget

Atacama Labs and Excella partner to sell PDG Granule and Tablet Manufacturing Services

Mosaic vaccines show promise in reducing HIV spread

Longer wait for radiation treatment after breast cancer surgery increases risk of recurrence in older women

Childhood absence epilepsy: Comparative clinical trial of widely used anti-seizure drugs

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News